G

Genesis Therapeutics

47 employees

Genesis Therapeutics unifies AI and biotech to accelerate the discovery of new medicines.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Information Technology
Artificial Intelligence
Drug Development
Drug Discovery
Deep Learning

Date founded

2019

Funding rounds raised

Total raised

$200M

from 16 investors over 16 rounds

G

Genesis Therapeutics raised $200M on August 21, 2023

Investors: Radical Ventures, Menlo Ventures, T. Rowe Price, Andreessen Horowitz and nVentures PTE LTD

G

Genesis Therapeutics raised $52M on December 2, 2020

Investors: T. Rowe Price, Radical Ventures, Propagator Ventures, -, Menlo Ventures, Ulu Ventures and JAZZ Venture Partners

G

Genesis Therapeutics raised undisclosed on June 2, 2020

Investors: Ulu Ventures

G

Genesis Therapeutics raised undisclosed on April 1, 2020

Investors: Harpoon Ventures

G

Genesis Therapeutics raised $4.1M on November 21, 2019

Investors: Felicis Ventures and Andreessen Horowitz

FAQ